目的验证阿莫西林克拉维酸钾口服并头孢他啶静脉滴注治疗急性期慢性阻塞性肺疾病疗效。方法将460例急性期慢性阻塞性肺疾病患者依照入我院治疗前后次序加入研究组或对照组，均230例。分别予阿莫西林克拉维酸钾口服并头孢他啶静脉滴注及单独使用头孢他啶静滴，疗程结束后比较两组有效率及不良反应出现情况。结果实验性结束治疗后，研究组及对照组总有效率分别为94.8%、81.3%，经比较<0.05，有差异。结论阿莫西林克拉维酸钾口服并头孢他啶静脉滴注治疗AECOPD效果较佳，适于普遍推广使用。%Objective To verify the clinical ef ect of amoxicillin and clavulanate potassium po.combined ceftazidime ivgtt.for treatment of acute stage of COPD.Methods 460 patients with acute stage of COPD were divided into study group and control group both with 230 cases according to precedence order.And they were given amoxicil in and clavulanate potassium po.combined ceftazidime ivgt .And single ceftazidime ivgt .respectively.Effective rate and adverse ef ect rate of the 2 groups were compared after treatment course.Results After treatment,total ef ective rate of study group and control group were respectively 94.8% and 81.3%, <0.05.Conclusion Amoxicil in and clavulanate potassium po.combined ceftazidime ivgt .for treatment of acute stage of COPD has good clinical ef ect and is worth of being popularized.
展开▼
